Table S2. Mass Spectrometry Based Quantitation (LFQ Scores) of Proteins Co-Purifying from Yeast with Exoy-TAP

Total Page:16

File Type:pdf, Size:1020Kb

Table S2. Mass Spectrometry Based Quantitation (LFQ Scores) of Proteins Co-Purifying from Yeast with Exoy-TAP Table S2. Mass spectrometry based quantitation (LFQ scores) of proteins co-purifying from yeast with ExoY-TAP. PEP - posterior error probability - the probability of a false hit given the peptide identification score and length of peptides (defined in Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide quantitation. Nat Biotechnol. 2008 Dec;26(12):1367-72. doi: 10.1038/nbt.1511.) LFQ - Label Free Quantitation score - proportional to the average peptide signal intensity for all the peptides used to identify a given protein. Approximates the relative amounts of protein and can be used to compare protein levels between two conditions. Uniprot Description Gene Number Number PEP log2(LFQ) log2(LFQ) identifier names of of control TAP-ExoY similar unique identi- peptides fied for proteins protein identify- cation P07342 Acetolactate synthase catalytic subunit, ILV2 1 27 8.77E-214 29.174 26.40759 mitochondrial Q87022 Probable RNA-directed RNA polymerase;Major gag- 4 26 1.42E-267 28.34672 28.81559 ;P32503;Q capsid protein pol;gag 87024 P25605 Acetolactate synthase small subunit, ILV6 1 14 7.28E-99 28.14865 25.68654 mitochondrial P23172; Probable RNA-directed RNA polymerase;Major gag- 216 1.63E-75 25.06163 20.40561 Q87026 capsid protein pol;gag P02994 Elongation factor 1-alpha TEF1 1 14 1.47E-75 24.22957 25.30567 P10591 Heat shock protein SSA1 SSA1 2 8 2.54E-173 23.31451 25.41361 P04147 Polyadenylate-binding protein, cytoplasmic and PAB1 126 1.06E-95 23.29782 23.92488 nuclear Q00955 Acetyl-CoA carboxylase;Biotin carboxylase ACC1 2 44 1.54E-164 23.02989 20.97337 P0C2I6;P0 Transposon Ty1-LR3 Gag-Pol polyprotein;Capsid TY1B- 57 3 1.88E-88 22.48395 23.64713 C2I9;P0C2 protein;Ty1 protease;Integrase; Reverse LR3;TY1B- J1;P47098 transcriptase/ribonuclease H (Rev. t./r. PR1;TY1B- ;Q03434; H);Transposon Ty1-PR1 Gag-Pol polyprotein;Capsid PR3;TY1B- Q03612;P protein;Ty1 protease;Integrase;Rev. t./r. JR1;TY1B- 0C2I3;P0C H;Transposon Ty1-PR3 Gag-Pol polyprotein;Capsid ML2;TY1B 2I5;P0C2I7 protein;Ty1 protease;Integrase;Rev. t./r. - ;Q12414;P H;Transposon Ty1-JR1 Gag-Pol polyprotein;Capsid ER1;TY1B- 0C2J0;P47 protein;Ty1 protease;Integrase;Rev. t./r. DR6;TY1B- 100;Q121 H;Transposon Ty1-ML2 Gag-Pol polyprotein;Capsid LR2;TY1B- 41;P0C2I2; protein;Ty1 protease;Integrase;Rev. t./r. LR4;TY1B- Q12269;Q H;Transposon Ty1-ER1 Gag-Pol polyprotein;Capsid PL;TY1B- 12273;Q0 protein;Ty1 protease;Integrase;Rev. t./r. PR2;TY1B- 4711;Q07 H;Transposon Ty1-DR6 Gag-Pol polyprotein;Capsid JR2;TY1B- 793;O135 protein;Ty1 protease;Integrase;Rev. t./r. GR1;TY1B- 35;Q0467 H;Transposon Ty1-LR2 Gag-Pol polyprotein;Capsid DR5;TY1B- 0;Q92393; protein;Ty1 protease;Integrase;Rev. t./r. GR2;TY1B- Q03855;Q H;Transposon Ty1-LR4 Gag-Pol polyprotein;Capsid OL;TY1B- 12193;Q0 protein;Ty1 protease;Integrase;Rev. t./r. ML1;TY1B 3619;Q12 H;Transposon Ty1-PL Gag-Pol polyprotein;Capsid - 088;Q123 protein;Ty1 protease;Integrase;Rev. t./r. DR4;TY1B- 16;Q9923 H;Transposon Ty1-PR2 Gag-Pol polyprotein;Capsid H;TY1B- 1;Q99337; protein;Ty1 protease;Integrase;Rev. t./r. MR2;TY1B O13527 H;Transposon Ty1-JR2 Gag-Pol polyprotein;Capsid -OR;TY1B- protein;Ty1 protease;Integrase;Rev. t./r. DR1;TY1B- H;Transposon Ty1-GR1 Gag-Pol polyprotein;Capsid BR;TY1B- protein;Ty1 protease;Integrase;Rev. t./r. ER2;TY1B- H;Transposon Ty1-DR5 Gag-Pol polyprotein;Capsid LR1;TY1B- protein;Ty1 protease;Integrase;Rev. t./r. GR3;TY1B- H;Transposon Ty1-GR2 Gag-Pol polyprotein;Capsid DR3;TY1B- protein;Ty1 protease;Integrase;Rev. t./r. NL2;TY1B- H;Transposon Ty1-OL Gag-Pol polyprotein;Capsid A protein;Ty1 protease;Integrase;Rev. t./r. H;Transposon Ty1-ML1 Gag-Pol polyprotein;Capsid protein;Ty1 protease;Integrase;Rev. t./r. H;Transposon Ty1-DR4 Gag-Pol polyprotein;Capsid protein;Ty1 protease;Integrase;Rev. t./r. H;Transposon Ty1-H Gag-Pol polyprotein;Capsid protein;Ty1 protease;Integrase;Rev. t./r. H;Transposon Ty1-MR2 Gag-Pol polyprotein;Capsid protein;Ty1 protease;Integrase;Rev. t./r. H;Transposon Ty1-OR Gag-Pol polyprotein;Capsid protein;Ty1 protease;Integrase;Rev. t./r. H;Transposon Ty1-DR1 Gag-Pol polyprotein;Capsid protein;Ty1 protease;Integrase;Rev. t./r. H;Transposon Ty1-BR Gag-Pol polyprotein;Capsid protein;Ty1 protease;Integrase;Rev. t./r. H;Transposon Ty1-ER2 Gag-Pol polyprotein;Capsid protein;Ty1 protease;Integrase;Rev. t./r. H;Transposon Ty1-LR1 Gag-Pol polyprotein;Capsid protein;Ty1 protease;Integrase;Rev. t./r. H;Transposon Ty1-GR3 Gag-Pol polyprotein;Capsid protein;Ty1 protease;Integrase;Rev. t./r. H;Transposon Ty1-DR3 Gag-Pol polyprotein;Capsid protein;Ty1 protease;Integrase;Rev. t./r. H;Transposon Ty1-NL2 Gag-Pol polyprotein;Capsid protein;Ty1 protease;Integrase;Rev. t./r. H;Truncated transposon Ty1-A Gag-Pol polyprotein;Integrase;Rev. t./r. H P32324 Elongation factor 2 EFT1 1 22 2.20E-91 22.08787 22.89421 P00925 Enolase 2 ENO2 1 8 1.53E-72 21.85441 21.80104 P00359; Glyceraldehyde-3-phosphate dehydrogenase TDH3;T 27 7.95E-37 21.84782 22.01522 P00358 3;Glyceraldehyde-3-phosphate dehydrogenase 2 DH2 P04385 Galactokinase GAL1 2 18 5.97E-76 21.82209 22.63668 P00560 Phosphoglycerate kinase PGK1 1 16 1.19E-66 21.61827 21.80589 P06634 ATP-dependent RNA helicase DED1 DED1 2 21 2.06E-100 21.53521 23.9657 P00549 Pyruvate kinase 1 CDC19 213 1.88E-48 21.5243 22.82557 P04911; Histone H2A.1;Histone H2A.2 HTA1;H 2 2 2.44E-13 21.33527 23.03391 P04912 TA2 P53865 Chaotic nuclear migration protein 67 CNM67 1 14 1.26E-58 21.33473 18.91132 Q06010 A-factor-processing enzyme STE23 116 9.44E-48 21.10815 17.92515 P38011 Guanine nucleotide-binding protein subunit beta- ASC1 1 9 1.99E-40 21.10764 22.89462 like protein P04397 Bifunctional protein GAL10;UDP-glucose 4- GAL10 119 2.75E-89 21.02168 22.0254 epimerase;Aldose 1-epimerase P02309 Histone H4 HHF1 1 5 1.95E-57 20.83399 22.83389 P09624 Dihydrolipoyl dehydrogenase, mitochondrial LPD1 1 9 8.46E-43 20.80971 17.60161 P15646 rRNA 2-O-methyltransferase fibrillarin NOP1 1 9 2.04E-37 20.74435 22.4207 P0C0V8 40S ribosomal protein S21-A;40S ribosomal RPS21A 26 2.32E-25 20.70016 21.91138 ;Q3E754 protein S21-B ;RPS21B P32473 Pyruvate dehydrogenase E1 component subunit PDB1 1 5 9.33E-22 20.61495 17.82488 beta, mitochondrial P0CX53; 60S ribosomal protein L12-A;60S ribosomal RPL12A; 27 1.25E-55 20.59696 23.06067 P0CX54 protein L12-B RPL12B P38631 1,3-beta-glucan synthase component FKS1 FKS1 1 12 7.93E-95 20.54576 21.86302 P10080 Single-stranded nucleic acid-binding protein SBP1 1 9 1.73E-26 20.53241 22.00898 P00330 Alcohol dehydrogenase 1 ADH1 38 2.40E-34 20.49921 20.72783 P32905; 40S ribosomal protein S0-A;40S ribosomal protein RPS0A; 2 7 3.89E-26 20.47833 22.33535 P46654 S0-B RPS0B P39990 13 kDa ribonucleoprotein-associated protein SNU13 1 5 5.61E-16 20.44374 21.45443 P46784; 40S ribosomal protein S10-B;40S ribosomal RPS10B 23 5.05E-15 20.42008 22.01591 Q08745 protein S10-A ;RPS10A P05030; Plasma membrane ATPase 1;Plasma membrane PMA1;P 2 15 2.06E-64 20.41183 20.51326 P19657 ATPase 2 MA2 O14467 Multiprotein-bridging factor 1 MBF1 17 2.28E-25 20.31307 20.78429 P38701 40S ribosomal protein S20 RPS20 1 4 1.96E-28 20.23608 21.08083 P12695 Dihydrolipoyllysine-residue acetyltransferase LAT1 1 5 1.07E-19 20.194 17.39632 component of pyruvate dehydrogenase complex, mitochondrial P04840 Mitochondrial outer membrane protein porin 1 POR1 1 10 1.42E-39 20.03604 21.43959 P16387 Pyruvate dehydrogenase E1 component subunit PDA1 15 9.63E-30 20.0084 17.99899 alpha, mitochondrial P24276 Protein SSD1 SSD1 130 3.39E-103 19.99673 22.49865 P37292 Serine hydroxymethyltransferase, mitochondrial SHM1 1 8 2.68E-62 19.83686 19.71453 P00950 Phosphoglycerate mutase 1 GPM1 1 8 2.32E-29 19.79983 19.73945 P32380 Spindle pole body component 110 SPC110 1 9 8.93E-33 19.79425 17.33769 Q01560 Nucleolar protein 3 NPL3 17 4.66E-25 19.78982 21.26774 P02400 60S acidic ribosomal protein P2-beta RPP2B 1 3 4.51E-48 19.58632 21.95642 P41940 Mannose-1-phosphate guanyltransferase PSA1 1 7 1.27E-23 19.57917 19.40279 P0CX49; 60S ribosomal protein L18-A;60S ribosomal RPL18A; 2 5 1.69E-71 19.57723 22.5724 P0CX50 protein L18-B RPL18B P10592 Heat shock protein SSA2 SSA2 2 7 2.63E-167 19.51324 21.71695 P08431 Galactose-1-phosphate uridylyltransferase GAL7 1 11 2.36E-45 19.47799 20.72692 P14832 Peptidyl-prolyl cis-trans isomerase CPR1 1 5 1.06E-19 19.44996 18.86912 P0CX23; 60S ribosomal protein L20-A;60S ribosomal RPL20A; 26 9.24E-28 19.42597 22.3531 P0CX24 protein L20-B RPL20B P0CX55; 40S ribosomal protein S18-A;40S ribosomal RPS18A 2 8 7.74E-40 19.33604 21.74891 P0CX56 protein S18-B ;RPS18B P04456 60S ribosomal protein L25 RPL25 15 1.49E-21 19.30354 21.98329 P15992 Heat shock protein 26 HSP26 1 6 2.20E-23 19.23121 19.40949 P21373 NAD(+) kinase UTR1 1 9 4.43E-51 19.04695 20.59377 P0CX82; 60S ribosomal protein L19-A;60S ribosomal RPL19A; 2 5 6.33E-53 19.04033 21.96877 P0CX83 protein L19-B RPL19B Q12499 Nucleolar protein 58 NOP58 1 14 2.71E-53 19.03023 21.85605 Q12159 RNA annealing protein YRA1 YRA1 1 7 1.38E-26 19.01947 21.25084 P02406 60S ribosomal protein L28 RPL28 1 4 3.02E-11 18.98782 21.02817 P32445 Single-stranded DNA-binding protein RIM1, RIM1 1 4 2.54E-13 18.97418 19.36329 mitochondrial P02407; 40S ribosomal protein S17-A;40S ribosomal RPS17A 2 4 5.48E-47 18.9605 21.31744 P14127 protein S17-B ;RPS17B P32787 Mitochondrial genome maintenance protein MGM1 14 3.54E-14 18.95359 19.76912 MGM101 01 P05317 60S acidic ribosomal protein P0 RPP0 1 9 1.09E-33 18.93509 23.51797 P0C2H6 60S ribosomal protein L27-A;60S ribosomal RPL27A; 2 5 1.82E-19 18.8845 21.94292 ;P0C2H7
Recommended publications
  • C8cc08685k1.Pdf
    Electronic Supplementary Material (ESI) for ChemComm. This journal is © The Royal Society of Chemistry 2018 Supporting Information Minimalist Linkers Suitable for Irreversible Inhibitors in Simultaneous Proteome Profiling, Live-Cell Imaging and Drug Screening Cuiping Guo,Yu Chang, Xin Wang, Chengqian Zhang, Piliang Hao*, Ke Ding and Zhengqiu Li* School of Pharmacy, Jinan University, Guangzhou, China 510632 *Corresponding author ([email protected]) 1. General Information All chemicals were purchased from commercial vendors and used without further purification, unless indicated otherwise. All reactions requiring anhydrous conditions were carried out under argon or nitrogen atmosphere using oven-dried glassware. AR-grade solvents were used for all reactions. Reaction progress was monitored by TLC on pre-coated silica plates (Merck 60 F254 nm, 0.25 µm) and spots were visualized by UV, iodine or other suitable stains. Flash column chromatography was carried out using silica gel (Qingdao Ocean). All NMR spectra (1H-NMR, 13C-NMR) were recorded on Bruker 300 MHz/400 MHz NMR spectrometers. Chemical shifts were reported in parts per million (ppm) referenced with respect to appropriate internal standards or residual solvent peaks (CDCl3 = 7.26 ppm, DMSO-d6 = 2.50 ppm). The following abbreviations were used in reporting spectra, br s (broad singlet), s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), dd (doublet of doublets). Mass spectra were obtained on Agilent LC-ESI-MS system. All analytical HPLC were carried out on Agilent system. Water with 0.1% TFA and acetonitrile with 0.1% TFA were used as eluents and the flow rate was 0.5 mL/min.
    [Show full text]
  • The Rise and Fall of the Bovine Corpus Luteum
    University of Nebraska Medical Center DigitalCommons@UNMC Theses & Dissertations Graduate Studies Spring 5-6-2017 The Rise and Fall of the Bovine Corpus Luteum Heather Talbott University of Nebraska Medical Center Follow this and additional works at: https://digitalcommons.unmc.edu/etd Part of the Biochemistry Commons, Molecular Biology Commons, and the Obstetrics and Gynecology Commons Recommended Citation Talbott, Heather, "The Rise and Fall of the Bovine Corpus Luteum" (2017). Theses & Dissertations. 207. https://digitalcommons.unmc.edu/etd/207 This Dissertation is brought to you for free and open access by the Graduate Studies at DigitalCommons@UNMC. It has been accepted for inclusion in Theses & Dissertations by an authorized administrator of DigitalCommons@UNMC. For more information, please contact [email protected]. THE RISE AND FALL OF THE BOVINE CORPUS LUTEUM by Heather Talbott A DISSERTATION Presented to the Faculty of the University of Nebraska Graduate College in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy Biochemistry and Molecular Biology Graduate Program Under the Supervision of Professor John S. Davis University of Nebraska Medical Center Omaha, Nebraska May, 2017 Supervisory Committee: Carol A. Casey, Ph.D. Andrea S. Cupp, Ph.D. Parmender P. Mehta, Ph.D. Justin L. Mott, Ph.D. i ACKNOWLEDGEMENTS This dissertation was supported by the Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture (NIFA) Pre-doctoral award; University of Nebraska Medical Center Graduate Student Assistantship; University of Nebraska Medical Center Exceptional Incoming Graduate Student Award; the VA Nebraska-Western Iowa Health Care System Department of Veterans Affairs; and The Olson Center for Women’s Health, Department of Obstetrics and Gynecology, Nebraska Medical Center.
    [Show full text]
  • Reprogramming of Trna Modifications Controls the Oxidative Stress Response by Codon-Biased Translation of Proteins
    Reprogramming of tRNA modifications controls the oxidative stress response by codon-biased translation of proteins The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation Chan, Clement T.Y. et al. “Reprogramming of tRNA Modifications Controls the Oxidative Stress Response by Codon-biased Translation of Proteins.” Nature Communications 3 (2012): 937. As Published http://dx.doi.org/10.1038/ncomms1938 Publisher Nature Publishing Group Version Author's final manuscript Citable link http://hdl.handle.net/1721.1/76775 Terms of Use Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use. Reprogramming of tRNA modifications controls the oxidative stress response by codon-biased translation of proteins Clement T.Y. Chan,1,2 Yan Ling Joy Pang,1 Wenjun Deng,1 I. Ramesh Babu,1 Madhu Dyavaiah,3 Thomas J. Begley3 and Peter C. Dedon1,4* 1Department of Biological Engineering, 2Department of Chemistry and 4Center for Environmental Health Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139; 3College of Nanoscale Science and Engineering, University at Albany, SUNY, Albany, NY 12203 * Corresponding author: PCD, Department of Biological Engineering, NE47-277, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139; tel 617-253-8017; fax 617-324-7554; email [email protected] 2 ABSTRACT Selective translation of survival proteins is an important facet of cellular stress response. We recently demonstrated that this translational control involves a stress-specific reprogramming of modified ribonucleosides in tRNA.
    [Show full text]
  • Allele-Specific Expression of Ribosomal Protein Genes in Interspecific Hybrid Catfish
    Allele-specific Expression of Ribosomal Protein Genes in Interspecific Hybrid Catfish by Ailu Chen A dissertation submitted to the Graduate Faculty of Auburn University in partial fulfillment of the requirements for the Degree of Doctor of Philosophy Auburn, Alabama August 1, 2015 Keywords: catfish, interspecific hybrids, allele-specific expression, ribosomal protein Copyright 2015 by Ailu Chen Approved by Zhanjiang Liu, Chair, Professor, School of Fisheries, Aquaculture and Aquatic Sciences Nannan Liu, Professor, Entomology and Plant Pathology Eric Peatman, Associate Professor, School of Fisheries, Aquaculture and Aquatic Sciences Aaron M. Rashotte, Associate Professor, Biological Sciences Abstract Interspecific hybridization results in a vast reservoir of allelic variations, which may potentially contribute to phenotypical enhancement in the hybrids. Whether the allelic variations are related to the downstream phenotypic differences of interspecific hybrid is still an open question. The recently developed genome-wide allele-specific approaches that harness high- throughput sequencing technology allow direct quantification of allelic variations and gene expression patterns. In this work, I investigated allele-specific expression (ASE) pattern using RNA-Seq datasets generated from interspecific catfish hybrids. The objective of the study is to determine the ASE genes and pathways in which they are involved. Specifically, my study investigated ASE-SNPs, ASE-genes, parent-of-origins of ASE allele and how ASE would possibly contribute to heterosis. My data showed that ASE was operating in the interspecific catfish system. Of the 66,251 and 177,841 SNPs identified from the datasets of the liver and gill, 5,420 (8.2%) and 13,390 (7.5%) SNPs were identified as significant ASE-SNPs, respectively.
    [Show full text]
  • Supplemental Data
    SUPPLEMENTAL INFORMATION Glomerular cell crosstalk influences composition and assembly of extracellular matrix Adam Byron,1,*,† Michael J. Randles,1,2,† Jonathan D. Humphries,1 Aleksandr Mironov,1 Hellyeh Hamidi,1 Shelley Harris,2 Peter W. Mathieson,3 Moin A. Saleem,3 Simon S. Satchell,3 Roy Zent,4,5 Martin J. Humphries,1 and Rachel Lennon.1,2 1Wellcome Trust Centre for Cell-Matrix Research, Faculty of Life Sciences, University of Manchester, Manchester, UK; 2Faculty of Medical and Human Sciences, University of Manchester, Manchester, UK; 3Academic Renal Unit, Faculty of Medicine and Dentistry, University of Bristol, Bristol, UK; 4Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA; and 5Veterans Affairs Hospital, Nashville, TN, USA. *Present address: Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK. †These authors contributed equally to this work. Corresponding author: Dr Rachel Lennon, Wellcome Trust Centre for Cell-Matrix Research, Michael Smith Building, University of Manchester, Manchester M13 9PT, UK. Phone: 0044 (0) 161 2755498. Fax: 0044 (0) 161 2755082. Email: [email protected] Supplementary methods Non-glomerular cell culture HEK 293T and human foreskin fibroblasts were cultured until confluent in Dulbecco's Modified Eagle Medium supplemented with 10% foetal calf serum. Lentiviral production and transduction Podocytes stably expressing GFP were produced by lentiviral transduction. Briefly, HEK 293T cells were transfected with three plasmids obtained from Addgene (psPAX2 Addgene ID 12260, pMD2.G Addgene ID 12259 and pWPXL Addgene ID 12257) using polyethyleneimine (Sigma-Aldrich). Conditioned medium containing viruses was collected after 5 days following several media changes including an 8 hr incubation with sodium butyrate- containing media to promote virus production.
    [Show full text]
  • Supplementary Materials
    1 Supplementary Materials: Supplemental Figure 1. Gene expression profiles of kidneys in the Fcgr2b-/- and Fcgr2b-/-. Stinggt/gt mice. (A) A heat map of microarray data show the genes that significantly changed up to 2 fold compared between Fcgr2b-/- and Fcgr2b-/-. Stinggt/gt mice (N=4 mice per group; p<0.05). Data show in log2 (sample/wild-type). 2 Supplemental Figure 2. Sting signaling is essential for immuno-phenotypes of the Fcgr2b-/-lupus mice. (A-C) Flow cytometry analysis of splenocytes isolated from wild-type, Fcgr2b-/- and Fcgr2b-/-. Stinggt/gt mice at the age of 6-7 months (N= 13-14 per group). Data shown in the percentage of (A) CD4+ ICOS+ cells, (B) B220+ I-Ab+ cells and (C) CD138+ cells. Data show as mean ± SEM (*p < 0.05, **p<0.01 and ***p<0.001). 3 Supplemental Figure 3. Phenotypes of Sting activated dendritic cells. (A) Representative of western blot analysis from immunoprecipitation with Sting of Fcgr2b-/- mice (N= 4). The band was shown in STING protein of activated BMDC with DMXAA at 0, 3 and 6 hr. and phosphorylation of STING at Ser357. (B) Mass spectra of phosphorylation of STING at Ser357 of activated BMDC from Fcgr2b-/- mice after stimulated with DMXAA for 3 hour and followed by immunoprecipitation with STING. (C) Sting-activated BMDC were co-cultured with LYN inhibitor PP2 and analyzed by flow cytometry, which showed the mean fluorescence intensity (MFI) of IAb expressing DC (N = 3 mice per group). 4 Supplemental Table 1. Lists of up and down of regulated proteins Accession No.
    [Show full text]
  • Swissprot Genetrail Acc. No. ID Exp1 Exp2 Exp1 Exp2 Exp1 Exp2
    Supplementary TABLE 1. Quantitative MS-based proteomic results from the macrophage cytosolic proteomes for both biological replicates separately Human proteins HSV-1 dLeu d3-4 Protein name SwissProt Genetrail N % Seq Cov Pept(95%) Fold change P-value Fold change P-value Fold change P-value Acc. No. ID Exp1 Exp2 Exp1 Exp2 Exp1 Exp2 Exp1 Exp2 Exp1 Exp2 Exp1 Exp2 Exp1 Exp2 Exp1 Exp2 Exp1 Exp2 10 kDa heat shock protein, mitochondrial P61604 HSPE1 121 108 69,6 65,7 9 18 1,24 1,11 0,014 0,141 1,12 1,16 0,127 0,054 1,07 0,96 0,290 0,529 14-3-3 protein beta/alpha P31946 YWHAB 350 145 37 52,9 13 16 1,10 0,97 0,409 0,743 1,12 0,72 0,651 0,184 1,04 0,72 0,730 0,101 14-3-3 protein epsilon P62258 YWHAE 661 524 16,5 24,7 5 8 1,43 1,00 0,996 0,60 0,78 0,238 0,84 0,87 0,765 14-3-3 protein eta Q04917 YWHAH 572 376 36,2 34,6 9 10 0,77 1,00 1,30 14-3-3 protein gamma P61981 YWHAG 135 358 38,1 35,2 13 10 1,93 1,21 0,170 1,10 0,44 0,515 1,88 1,17 0,099 14-3-3 protein theta P27348 YWHAQ 659 596 20,4 43,7 7 8 1,12 0,72 1,16 14-3-3 protein zeta/delta P63104 YWHAZ 59 36 45,3 54,7 15 19 1,48 1,33 0,004 0,019 1,22 0,95 0,265 0,570 1,08 1,10 0,315 0,416 182 kDa tankyrase-1-binding protein Q9C0C2 TNKS1BP1 517 2,7 2 0,89 0,874 1,18 0,345 1,06 0,651 1-phosphatidylinositol 4,5-bisphosphate phosphodiesteraseQ00722 beta-2 PLCB2 291 9,1 3 0,67 0,290 0,65 0,046 0,94 0,793 2,4-dienoyl-CoA reductase, mitochondrial Q16698 DECR1 335 14,3 4 0,76 0,284 0,97 0,841 0,91 0,415 26S proteasome non-ATPase regulatory subunit 11 O00231 PSMD11 375 18,7 3 1,43 1,19 0,93 26S proteasome non-ATPase
    [Show full text]
  • Figure S1. Quality Control Validation of MS Data. (A‑C) Mass Error Distribution of All Peptides Identified in the Acetylome
    Figure S1. Quality control validation of MS data. (A‑C) Mass error distribution of all peptides identified in the acetylome, succi- nylome and quantitative proteome, respectively. (D‑F) Length distribution of peptides identified in the acetylome, succinylome and quantitative proteome, respectively. Figure S2. Comparison of modification level between breast cancer tissue and normal tissue. Comparison of acetylation level (A) and succinylation level (B) between breast cancer tissue and normal tissue. Data are medians and were analyzed using Wilcoxon Signed Rank Test. **P<0.01. Table SI. Protein sites whose acetylation and succinylation levels were both significantly upregulated in breast cancer tissues (fold change ≥1.5 compared with normal tissues). Protein ID Protein name Modification site P54868 HMCS2 310K Q15063 POSTN 549K Q99715 COCA1 1601K P51572 BAP31 72K P07237 PDLA1 328K Q06830 PRDX1 192K P48735 IDHP 180K P30101 PDIA3 417K P0DMV9 HS71B 526K Q01995 TAGL 21K P06748 NPM1 27K Q00325 MPCP 209K P00488 F13A 69K P02545 LMNA 260K P08133 ANXA6 478K P02452 CO1A1 751K Table SII. Protein sites whose acetylation and succinylation levels were both significantly downregulated in breast cancer tissues (fold change ≥1.5 compared with normal tissues). Protein ID Protein name Modification site RET4 P02753 30K PSG2 P07585 142K HBA P69905 12K IGKC P01834 80K HBA P69905 8K Table SIII. All proteins whose expression level were significantly upregulated in breast cancer tissues (fold change ≥1.5 compared with normal tissues). Protein ID Protein description
    [Show full text]
  • Immunoprecipitation and Mass Spectrometry Defines an Extensive
    BRES : 44759 Model7 pp: À 1221ðcol:fig: : NILÞ brain research ] ( ]]]]) ]]]– ]]] Available online at www.sciencedirect.com 121 122 123 124 125 126 www.elsevier.com/locate/brainres 127 128 129 Review 130 131 fi 132 Immunoprecipitation and mass spectrometry de nes 133 – 134 an extensive RBM45 protein protein interaction 135 Q2 136 network 137 138 a a,b a a c 139 Yang Li , Mahlon Collins , Jiyan An , Rachel Geiser , Tony Tegeler , c c c a,b,n 140 Q1 Kristine Tsantilas , Krystine Garcia , Patrick Pirrotte , Robert Bowser 141 aDivisions of Neurology and Neurobiology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, 142 Phoenix, AZ 85013, USA 143 bUniversity of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA 144 cCenter for Proteomics, TGen (Translational Genomics Research Institute), Phoenix, AZ 85004, USA 145 146 147 article info abstract 148 149 Article history: The pathological accumulation of RNA-binding proteins (RBPs) within inclusion bodies is a 150 Received 30 January 2016 hallmark of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration 151 Received in revised form (FTLD). RBP aggregation results in both toxic gain and loss of normal function. Determining 152 25 February 2016 the protein binding partners and normal functions of disease-associated RBPs is necessary 153 Accepted 28 February 2016 to fully understand molecular mechanisms of RBPs in disease. Herein, we characterized 154 the protein–protein interactions (PPIs) of RBM45, a RBP that localizes to inclusions in ALS/ 155 – fi Keywords: FTLD. Using immunoprecipitation coupled to mass spectrometry (IP MS), we identi ed 132 156 fi RBM45 proteins that speci cally interact with RBM45 within HEK293 cells.
    [Show full text]
  • Allosteric Integrase Inhibitor Potency Is Determined Through the Inhibition of HIV-1 Particle Maturation
    Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturation Kellie A. Juradoa, Hao Wanga, Alison Slaughterb, Lei Fengb, Jacques J. Kesslb, Yasuhiro Koha, Weifeng Wanga, Allison Ballandras-Colasa, Pratiq A. Patelc, James R. Fuchsc, Mamuka Kvaratskheliab, and Alan Engelmana,1 aDepartment of Cancer Immunology and AIDS, Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, MA 02215; and bCenter for Retrovirus Research and Comprehensive Cancer Center and cDivision of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH 43210 Edited by Alan R. Rein, National Cancer Institute, Frederick, MD, and accepted by the Editorial Board April 1, 2013 (received for review January 14, 2013) Integration is essential for HIV-1 replication, and the viral integrase HIV-1 preferentially integrates along the bodies of active genes (IN) protein is an important therapeutic target. Allosteric IN inhib- (6), a trait that is largely attributable to an interaction between itors (ALLINIs) that engage the IN dimer interface at the binding site IN and the host protein lens epithelium-derived growth factor for the host protein lens epithelium-derived growth factor (LEDGF)/ (LEDGF)/transcriptional coactivator p75 (reviewed in refs. 7 and transcriptional coactivator p75 are an emerging class of small mole- 8). LEDGF/p75 functions as a bimodal tether during integration: cule antagonists. Consistent with the inhibition of a multivalent drug elements within its N-terminal region confer constitutive binding to target, ALLINIs display steep antiviral dose–response curves ex vivo. chromatin, whereas a downstream IN-binding domain (IBD) binds ALLINIs multimerize IN protein and concordantly block its assembly lentiviral IN proteins (9, 10).
    [Show full text]
  • Profilin-1 Is Required for Survival of Adult Hematopoietic Stem Cells
    Extended methods Immunohistochemistry HepG-2, SMMC-7721, and 293T cells were obtained from Cell Resource Center of Shanghai Institute for Biological Science, Chinese Academy Science, Shanghai, China. HUVEC cells were kindly provided by Prof. Ping-Jin Gao at Institute of Health Sciences (Shanghai, China). All these cell lines were cultured in DMEM with 10% FBS. MDA- MB-231 cell line was kindly provided by Prof. Ming-Yao Liu (East China Normal University, Shanghai, China) and was cultured in Leibovitz L-15 medium with 10% FBS. All these cell lines were originally purchased from ATCC. MDA-MB-231, SMMC-7721 or HepG2 cells were grown on coverslips in 24-well plates and fixed in either 4% paraformaldehyde or pre-chilled methanol (-20°C) for 10 min. In some cases, WT or VPS33B-null Lin-Sca-1+c-Kit+Flk2-CD34- LT-HSCs were collected by flow cytometry and fixed for immunofluorescence staining. Cells were then blocked with 3% BSA in PBS for 60 min followed by incubation with primary antibodies overnight. The antibodies used were anti-HA (Sigma), anti-Flag (Sigma), anti-VPS33B (Sigma), anti- VPS16B (Abcam), anti-GDI2 (Proteintech), anti-LAMP1 (Proteintech), anti-FLOT1 (Abways), anti-CD63 (Proteintech), anti-ANGPTL2 (R&D system), anti-ANGPTL3 (R&D system), anti-TPO (Abways), anti-GLUT1 (Proteintech), anti-LDHA (Proteintech), anti-PKM2 (CST), anti-RAB11A (Abways), anti-RAB27A (Abways) and anti-V5 (Biodragon). Fluorescent-conjugated secondary antibodies (Alexa Fluor® 488 or Alexa Fluor® 555) against mouse, rabbit, or goat were obtained from the Thermo Scientific Inc. The details for all the antibodies are listed in Table S3.
    [Show full text]
  • Scores Tag L1102 L1214 L1232 HOSE1 HOSE2 HS 1
    Scores Tag L1102 L1214 L1232 HOSE1 HOSE2 HS 1 CTGGAGGCTG 9.5 8.71 10.67 0 0 229335 1 CTGGAGGCTG 9.5 8.71 10.67 0 0 169350 1 CTGGAGGCTG 9.5 8.71 10.67 0 0 61384 1 CTGGAGGCTG 9.5 8.71 10.67 0 0 105633 1 CTGGAGGCTG 9.5 8.71 10.67 0 0 149152 1 GCAACTGTGA 7.77 8.71 6.67 0 0 169476 1 ATTTGTCCCA 14.68 7.62 5.33 0 0 57301 1 ATTTGTCCCA 14.68 7.62 5.33 0 0 356122 1 GTCGGGCCTC 71.65 39.18 22.67 1.16 0 73769 1 ATTCTCCAGT 35.39 39.18 44.01 85.74 89.13 458218 1 ATTCTCCAGT 35.39 39.18 44.01 85.74 89.13 406300 1 AGGGCTTCCA 56.98 37 69.35 134.4 141.05 458148 1 CTGCTATACG 11.22 14.15 9.34 41.71 38.94 180946 1 TTGGTGAAGG 10.36 18.5 17.34 61.41 49.32 426138 1 GCCGTGTCCG 21.58 9.79 8 54.45 58.84 356666 1 GCCGTGTCCG 21.58 9.79 8 54.45 58.84 380843 1 ACCCACGTCA 0.86 0 1.33 27.81 20.77 298184 1 ACCCACGTCA 0.86 0 1.33 27.81 20.77 400124 1 TCTCCATACC 0.86 1.09 0 23.17 25.09 1 CCCTTGTCCG 0.86 0 0 26.65 20.77 127824 1 CTTCTTGCCC 0 0 1.33 47.5 36.34 347939 1 CTTCTTGCCC 0 0 1.33 47.5 36.34 424220 1 CTGTACTTGT 0.86 0 0 63.72 29.42 75678 1 CCCAACGCGC 0 0 0 83.42 47.59 347939 1 GCAAGAAAGT 0 0 0 26.65 39.81 36977 1 GCAAGAAAGT 0 0 0 26.65 39.81 155376 1 ACACAGCAAG 0 0 0 23.17 15.58 1 AGCTTCCACC 0 0 0 11.59 7.79 355542 1 GAGTGGCTAC 0 0 0 9.27 6.92 1 ATGGTGGGGG 0 0 0 8.11 22.5 343586 1 AGATCCCAAG 0 0 0 5.79 8.65 50813 1 TGGAAGGAGG 0 0 0 8.11 6.06 1 TAGCCGGGAC 0 0 0 5.79 7.79 107740 1 TGTGGATGTG 0 0 0 4.63 12.11 180878 1 GGGTAGGGGG 0 0 0 34.76 9.52 13323 0.99 AATAAAGCAA 2.59 7.62 8 0 0 76698 0.99 AATAAAGCAA 2.59 7.62 8 0 0 126043 0.99 GGAACAAACA 8.63 3.26 18.67 0 0 375108
    [Show full text]